News & Events
Read our latest research news, explore upcoming events and find resources describing our mission and programs.
Latest News
NCATS Stories

Comprehensive Testing Confirms Quality of Tox21 Library’s Chemical Compounds
January 14, 2025 - NCATS News
- Assay Development and Screening Technology (ADST)
- Our Impact on Tools and Technologies
- Toxicology in the 21st Century (Tox21)
NCATS researchers assessed how well the Tox21 library’s chemicals hold up in real-world research conditions to ensure scientifically valid outcomes.
Read Article
NIH More Than Triples Its Investments in Digital Health Technology Research
January 3, 2025 - NCATS News
- Clinical and Translational Science Awards (CTSA) Program
- Informatics (IFX)
- Our Impact on Tools and Technologies
A new study by NCATS researchers showed that NIH has more than tripled its funding for research on digital health technologies in the last nine years.
Read ArticlePartner & Grantee News
U.S. Facing Critical Hospital Bed Shortage by 2032, UCLA Research Suggests
February 19, 2025 - Grantee/Partner News
- Clinical and Translational Science Awards (CTSA) Program
Turns Out, HSV Antivirals Are (and Aren’t) Skin-Deep
February 7, 2025 - Grantee/Partner News
- 3-D Tissue Bioprinting
- Assay Guidance Manual (AGM)
AI Tool Helps Find Life-Saving Medicine for Rare Disease
February 5, 2025 - Grantee/Partner News
- Biomedical Data Translator (Translator)
- Our Impact on Rare Diseases
Upcoming Events
NIH Rare Pair: Rare Disease Treatments Partnering Workshop
July 24, 2025 - July 25, 2025 - Workshop
Location: Mass General Brigham, Boston, Massachusetts
Join us for the NIH Rare Pair: Rare Disease Treatments Partnering Workshop, a pivotal event bringing together key contributors in the rare diseases ecosystem. Hosted by the National Institutes of Health (NIH), this workshop will take place July 24–25, 2025, at Mass General Brigham in Boston, Massachusetts.
This unique gathering will explore the rare diseases commercialization landscape from the diverse perspectives of industry leaders, private investors, government funders and patient advocacy organizations. Attendees will engage in dynamic panels and discussions addressing the challenges, opportunities and critical areas of interest in developing novel therapies for rare diseases.
Key highlights of the workshop include the following:
- Interactive Panels and Discussions: Gain insights into overcoming barriers and maximizing opportunities in the rare diseases treatment space.
- Rare Diseases Therapy Pitch Session: Listen to innovative NIH-supported investigators presenting cutting-edge treatments for rare diseases.
- Networking Opportunities: Build meaningful connections with researchers, investors and strategic partners driving advances in rare disease therapeutics.
Whether you’re a researcher, investor, advocate or industry professional, this workshop offers a unique opportunity to collaborate and accelerate the development of groundbreaking treatments for rare diseases.
Save the date and be part of the conversation that transforms ideas into treatments for patients with rare diseases.
Registration information and agenda will be coming soon.
Publications
Browse a listing of peer-reviewed scientific publications that feature research supported by NCATS programs and initiatives.
A Pilot Study Evaluating the Impact of an Algorithm-Driven Protocol on Guideline-Concordant Antibiotic Prescribing in a Rural Primary Care Setting
Clinical and Translational Science Awards (CTSA) Program - February 19, 2025 - Pharmacy
Read PublicationCirculating Nucleosomes and Histones in the Development of Lung Injury and Sepsis
Clinical and Translational Science Awards (CTSA) Program - February 19, 2025 - Current Issues in Molecular Biology
Read PublicationDrug Repurposing for Alzheimer’s Disease and Other Neurodegenerative Disorders
Clinical and Translational Science Awards (CTSA) Program - February 19, 2025 - Nature Communications
Read PublicationUnderstanding Depression in Autism: The Role of Subjective Perception and Anterior Cingulate Cortex Volume
Clinical and Translational Science Awards (CTSA) Program - February 10, 2025 - Molecular Autism
Read PublicationHealth Care Staffing Shortages and Potential National Hospital Bed Shortage
Clinical and Translational Science Awards (CTSA) Program - February 3, 2025 - JAMA Network Open
Read PublicationEffectiveness of Ventilation via an Endotracheal Tube in Pharynx Versus a Facemask in Patients With Potentially Difficult Airway: A Randomized, Crossover, and Blind Trial
Clinical and Translational Science Awards (CTSA) Program - February 1, 2025 - Anesthesia & Analgesia
Read PublicationWeight and Blood-Based Markers of Cachexia Predict Disability, Hospitalization and Worse Survival in Cancer Immunotherapy Patients
Clinical and Translational Science Awards (CTSA) Program - February 1, 2025 - Journal of Cachexia, Sarcopenia and Muscle
Read PublicationA Strategy for Simultaneous Engineering of Interspecies Cross-Reactivity, Thermostability, and Expression of a Bispecific 5T4 x CD3 DART® Molecule for Treatment of Solid Tumors
Assay Guidance Manual (AGM) - January 17, 2025 - Antibodies
Read PublicationBiomarker Investigation Using Multiple Brain Measures From MRI Through Explainable Artificial Intelligence in Alzheimer’s Disease Classification
Clinical and Translational Science Awards (CTSA) Program - January 17, 2025 - Bioengineering
Read PublicationMicroRNA Expression Profile in Acute Ischemic Stroke
Clinical and Translational Science Awards (CTSA) Program - January 17, 2025 - International Journal of Molecular Sciences
Read Publication